Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril versus nifedipine for hypertension control in children with post-streptococcal acute glomerulonephritis
ACTRN12611000778987Phase 3Recruiting
- Sponsor
- Universiti Sains Malaysia
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in poststreptococcal glomerulonephritis (APSGN) comparing Captopril arm with Nifedipine arm (2 arms). Primary endpoints: Blood pressure control by normalization of blood pressure and Blood pressure readings during admission. Started Mar 2011; status: recruiting.
02
Drugs
captoprilnifedipine
03
Conditions
poststreptococcal glomerulonephritis (APSGN)
Beyond the preview
Go deeper on ACTRN12611000778987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000778987.